{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:35:10Z","timestamp":1761824110092},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41440-019-0281-z","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T08:06:04Z","timestamp":1560413164000},"page":"1561-1571","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Health-related quality of life in blood pressure control and blood lipid-lowering therapies: results from the CHIEF randomized controlled trial"],"prefix":"10.1038","volume":"42","author":[{"name":"on behalf of the CHIEF Research Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohua","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Qiu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"281_CR1","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224\u201360.","journal-title":"Lancet"},{"key":"281_CR2","unstructured":"National Center for Cardiovascular Diseases. Report on cardiovascular disease in China. Beijing: Encyclopedia of China Publishing House; 2007."},{"key":"281_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.HYP.0000040263.94619.D5","volume":"40","author":"D Gu","year":"2002","unstructured":"Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40:920\u20137.","journal-title":"Hypertension"},{"key":"281_CR4","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.108.788166","volume":"118","author":"Y Wu","year":"2008","unstructured":"Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679\u201386.","journal-title":"Circulation"},{"key":"281_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/HJH.0000000000000745","volume":"34","author":"W Li","year":"2016","unstructured":"Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, et al. PURE China Investigators. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 2016;34:39\u201346.","journal-title":"J Hypertens"},{"key":"281_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/01.CIR.0000136583.52681.0D","volume":"110","author":"J He","year":"2004","unstructured":"He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, et al. InterASIA Collaborative Group. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation. 2004;110:405\u201311.","journal-title":"Circulation"},{"key":"281_CR7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/CIRCULATIONAHA.111.065904","volume":"125","author":"W Yang","year":"2012","unstructured":"Yang W, Xiao J, Yang Z, Ji L, Jia W, Weng J, et al. China National Diabetes and Metabolic Disorders Study Investigators. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125:2212\u201321.","journal-title":"Circulation"},{"key":"281_CR8","first-page":"680","volume":"35","author":"M Liu","year":"2014","unstructured":"Liu M, Li Y, Liu S, Wang W, Zhou M. Burden on blood-pressure-related diseases among the Chinese population, in 2010. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35:680\u20133.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"281_CR9","unstructured":"Liu M, Wang W, Ma L, Zhou M. Change on burden of diseases from hypercholesterolemia among the Chinese population from 1990 to 2010. Zhonghua Xin Xue Guan Bing Za Zhi 2015; 43: 802\u20135."},{"key":"281_CR10","first-page":"393","volume":"45","author":"R Van Hoof","year":"1990","unstructured":"Van Hoof R, Amery A, Fagard R, Staessen J. Quality of life during treatment of hypertensive patients with diuretics. Acta Cardiol. 1990;45:393\u2013401.","journal-title":"Acta Cardiol"},{"key":"281_CR11","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1001\/archinte.1994.00420190047006","volume":"154","author":"WB Applegate","year":"1994","unstructured":"Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154\u201360.","journal-title":"Arch Intern Med"},{"key":"281_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/archinte.1997.00440270080007","volume":"157","author":"RH Grimm Jr.","year":"1997","unstructured":"Grimm RH Jr., Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med. 1997;157:638\u201348.","journal-title":"Arch Intern Med"},{"key":"281_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/08037059709062095","volume":"6","author":"I Wiklund","year":"1997","unstructured":"Wiklund I, Halling K, Ryden-Bergsten T, Fletcher A. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press. 1997;6:357\u201364.","journal-title":"Blood Press"},{"key":"281_CR14","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/S0002-8223(99)00421-6","volume":"99","author":"CS Plaisted","year":"1999","unstructured":"Plaisted CS, Lin PH, Ard JD, McClure ML, Svetkey LP. The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc. 1999;99:S84\u20139.","journal-title":"J Am Diet Assoc"},{"key":"281_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.jhh.1001657","volume":"18","author":"A Degl\u2019Innocenti","year":"2004","unstructured":"Degl\u2019Innocenti A, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, et al. Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE). J Hum Hypertens. 2004;18:239\u201345.","journal-title":"J Hum Hypertens"},{"key":"281_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJM199603283341306","volume":"334","author":"MA Testa","year":"1996","unstructured":"Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835\u201340.","journal-title":"N Engl J Med"},{"key":"281_CR17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/hr.2017.80","volume":"40","author":"L Liu","year":"2017","unstructured":"Liu L, Li M, Song S, Shi A, Cheng S, Dang X, et al. Effects of long-term psychological intervention on blood pressure and health-related quality of life in patients with hypertension among the Chinese working population. Hypertens Res. 2017;40:999\u20131007.","journal-title":"Hypertens Res"},{"key":"281_CR18","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s11136-018-1928-y","volume":"27","author":"T Zhou","year":"2018","unstructured":"Zhou T, Guan H, Yao J, Xiong X, Ma A. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Qual Life Res. 2018;27:2799\u2013814.","journal-title":"Qual Life Res"},{"key":"281_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/jhh.2010.45","volume":"25","author":"W Wang","year":"2010","unstructured":"Wang W, Ma L, Zhang Y, Deng Q, Liu M, Liu L. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics. J Hum Hypertens. 2010;25:271\u20137.","journal-title":"J Hum Hypertens"},{"key":"281_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","volume":"372","author":"JGFM Robinson","year":"2015","unstructured":"Robinson JGFM, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, et al. TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372:1489\u201399.","journal-title":"N Engl J Med"},{"key":"281_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group.","year":"1990","unstructured":"EuroQol Group. EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"281_CR22","unstructured":"EuroQol Research Foundation. EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument. 2018. Available from: \n                    https:\/\/euroqol.org\/wp-content\/uploads\/2018\/12\/EQ-5D-3L-User-Guide_version-6.0.pdf"},{"key":"281_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341\u201353.","journal-title":"Health Econ"},{"key":"281_CR24","unstructured":"ICH Expert Working Group. ICH harmonised tripartite guideline: statistical principles for cllinical trials E9. 1998. Available from:\u00a0\n                    https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E9\/Step4\/E9_Guideline.pdf"},{"key":"281_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2307\/2530695","volume":"42","author":"RI Jennrich","year":"1986","unstructured":"Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics. 1986;42:805\u201320.","journal-title":"Biometrics"},{"key":"281_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons; 1987."},{"key":"281_CR27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","volume":"316","author":"GH Guyatt","year":"1998","unstructured":"Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Brit Med J. 1998;316:690\u20133.","journal-title":"Brit Med J"},{"key":"281_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00002281-200203000-00006","volume":"14","author":"DE Beaton","year":"2002","unstructured":"Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheuma. 2002;14:109\u201314.","journal-title":"Curr Opin Rheuma"},{"key":"281_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining minimal Clin important Differ Control Clin Trials. 1989;10:407\u201315.","journal-title":"Ascertaining minimal Clin important Differ Control Clin Trials"},{"key":"281_CR30","first-page":"582","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582\u201392.","journal-title":"Med Care"},{"key":"281_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0002-9149(01)01811-2","volume":"88","author":"M Falk","year":"2001","unstructured":"Falk M. Compliance with treatment and the art of medicine. Am J Cardiol. 2001;88:668\u20139.","journal-title":"Am J Cardiol"},{"key":"281_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s10198-003-0182-5","volume":"4","author":"W Greiner","year":"2003","unstructured":"Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ. 2003;4:222\u201331.","journal-title":"Eur J Health Econ"},{"key":"281_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2165\/00019053-199813040-00005","volume":"13","author":"JA Johnson","year":"1998","unstructured":"Johnson JA, Coons SJ, Ergo A, Szava-Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics. 1998;13:421\u201333.","journal-title":"Pharmacoeconomics"},{"key":"281_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.jhh.1000868","volume":"13","author":"FH Vanmolkot","year":"1999","unstructured":"Vanmolkot FH, de Hoon JN, van de Ven LL, Van Bortel LM. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide. J Hum Hypertens. 1999;13:559\u201363.","journal-title":"J Hum Hypertens"},{"key":"281_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/jhh.2011.48","volume":"26","author":"DJ Trevisol","year":"2012","unstructured":"Trevisol DJ, Moreira LB, Fuchs FD, Fuchs SC. Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study. J Hum Hypertens. 2012;26:374\u201380.","journal-title":"J Hum Hypertens"},{"key":"281_CR36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2337\/dc11-1868","volume":"35","author":"PJ O\u2019Connor","year":"2012","unstructured":"O\u2019Connor PJ, Narayan KM, Anderson R, Feeney P, Fine L, Ali MK, et al. Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial. Diabetes Care. 2012;35:1479\u201381.","journal-title":"Diabetes Care"},{"key":"281_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1611179","volume":"377","author":"DR Berlowitz","year":"2017","unstructured":"Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, et al. SPRINT research group. Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med. 2017;377:733\u201344.","journal-title":"N Engl J Med"},{"key":"281_CR38","first-page":"85","volume":"45","author":"L Lasaite","year":"2009","unstructured":"Lasaite L, Lasiene J, Kazanavicius G, Gostautas A. Associations of emotional state and quality of life with lipid concentration, duration of the disease, and the way of treating the disease in persons with type 2 diabetes mellitus. Med (Kaunas). 2009;45:85\u201394.","journal-title":"Med (Kaunas)"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0281-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0281-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0281-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:45Z","timestamp":1684617645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0281-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0281-z","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}